Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.24 USD | -0.88% | -1.74% | -11.76% |
23/05 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
23/05 | CRISPR Therapeutics Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.76% | 4.69B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Needham Adjusts Price Target on CRISPR Therapeutics to $88 From $90, Keeps Buy Rating